Effect of sodium-glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis.

Mehmet KanbayLaura TapoiCarina UrecheCem TanrioverEnes CevikAtalay DemirayBaris AfsarDavid Z I CherneyAdrian Covic

Published in: International urology and nephrology (2021)

SGLT2i led to significant increases in hemoglobin and hematocrit levels when compared to placebo. In addition to their cardiovascular effect, SGLT2i also increases hemoglobin and hematocrit levels.

Keyphrases

type diabetes
red blood cell
randomized controlled trial
clinical trial
skeletal muscle
glycemic control
metabolic syndrome